San Francisco's long history of HIV care leadership continues with strong demand for complete, well-tolerated single-tablet regimens. Spegra offers the Bay Area's uninsured and underinsured patients the same Dolutegravir-based therapy at dramatically reduced cost.
|
FAQ: Why is Dolutegravir specifically recommended in San Francisco HIV treatment guidelines? Dolutegravir-based regimens like Spegra have become preferred first-line therapy in most US and international guidelines due to their rapid viral suppression, high genetic barrier to resistance, and excellent tolerability with minimal drug interactions. San Francisco's HIV specialists, among the most experienced in the country, widely adopted Dolutegravir-based regimens early due to this strong efficacy and safety data. |
